DKFZ Researchers Unveil Dual-Inhibition Strategy for Tumors
Researchers at the German Cancer Research Center (DKFZ) in Heidelberg are investigating a dual-action therapeutic strategy designed to simultaneously inhibit tumor cell signaling and disrupt the tumor microenvironment. This experimental approach, detailed in recent laboratory findings, aims to overcome resistance mechanisms that often render conventional monotherapies ineffective in advanced solid tumors. Mechanisms of the Dual-Inhibition … Read more